Home
>
National Drug Code (NDC)
>
Leflunomide
Leflunomide - 16714-331-04 - (leflunomide)
Drug Information of Leflunomide
| Product NDC: | 16714-331 |
| Proprietary Name: | Leflunomide |
| Non Proprietary Name: | leflunomide |
| Active Ingredient(s): | 20 mg/1 & nbsp; leflunomide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Leflunomide
| Product NDC: | 16714-331 |
| Labeler Name: | NorthStar RxLLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091369 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110506 |
Package Information of Leflunomide
| Package NDC: | 16714-331-04 |
| Package Description: | 500 TABLET in 1 BOTTLE (16714-331-04) |
NDC Information of Leflunomide
| NDC Code | 16714-331-04 |
| Proprietary Name | Leflunomide |
| Package Description | 500 TABLET in 1 BOTTLE (16714-331-04) |
| Product NDC | 16714-331 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | leflunomide |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20110506 |
| Marketing Category Name | ANDA |
| Labeler Name | NorthStar RxLLC |
| Substance Name | LEFLUNOMIDE |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Antirheumatic Agent [EPC] |
